| Literature DB >> 8864124 |
T L O'Keefe1, G T Williams, S L Davies, M S Neuberger.
Abstract
CD22 is a surface glycoprotein of B lymphocytes that is rapidly phosphorylated on cytoplasmic tyrosines after antigen receptor cross-linking. Splenic B cells from mice with a disrupted CD22 gene were found to be hyperresponsive to receptor signaling: Heightened calcium fluxes and cell proliferation were obtained at lower ligand concentrations. The mice gave an augmented immune response, had an expanded peritoneal B-1 cell population, and contained increased serum titers of autoantibody. Thus, CD22 is a negative regulator of antigen receptor signaling whose onset of expression at the mature B cell stage may serve to raise the antigen concentration threshold required for B cell triggering.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8864124 DOI: 10.1126/science.274.5288.798
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728